Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dotatate Lutenium Lu-177

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis eyes $1B Lutathera acceleration with first-line win
    Novartis eyes $1B Lutathera acceleration with first-line win

    19 Jan 2024

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/novartis-eyeing-1b-acceleration-outlines-lutathera-win-newly-diagnosed-neuroendocrine-tumors

    Angus Liu FIERCE PHARMA
    19 Jan 2024
    Share Share
    Bicycle signs on new clinical execs in pipeline drive
    Bicycle signs on new clinical execs in pipeline drive

    10 May 2019

    // Kathy Wong ENDPTS

    https://endpts.com/bicycle-signs-on-new-clinical-execs-in-pipeline-drive-howard-stern-signs-on-as-fogpharma-cso/

    Kathy Wong ENDPTS
    10 May 2019
    Share Share
    Novartis exploring Saudi Arabia for production of cancer drugs
    Novartis exploring Saudi Arabia for production of cancer drugs

    10 May 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/novartis-sees-saudi-arabia-as-promising-market-for-producing-its-cancer-drugs

    Eric Palmer FIERCE PHARMA
    10 May 2019
    Share Share
    Did Novartis game Europe's orphan program to overprice Lutathera?
    Did Novartis game Europe's orphan program to overprice Lutathera?

    15 Jan 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/novartis-accused-gaming-ema-orphan-program-to-price-lutathera-price-sky-high

    Angus Liu FIERCE PHARMA
    15 Jan 2019
    Share Share